Day: August 3, 2020

CABORCA, Mexico, Aug. 03, 2020 (GLOBE NEWSWIRE) — Mexus Gold US (OTCQB: MXSG) (“Mexus” or the “Company) announced that production at its Santa Elena mine in Caborca, MX continues with positive results.   The company recently moved a 40 ton 6×6 articulated haul truck to the site which will allow for an increase in daily production.  In addition, the company is updating a 330 CAT excavator to keep pace with the increased production in Pit #1 on the Julio vein and shear zone.  Photos of Pit 1, overburden removal, and old workings.  Assaying of the material now being worked has shown up to 16 gpt Au with an average of 2.1 gpt Au.  Work on Phase 1 of 3 of the company’s build out of the heap leach pad continues.  Phase 1 includes the clearing of land and readying an area that will double the size of the current pad.   Ultimately,...

BERLIN, Aug. 03, 2020 (GLOBE NEWSWIRE) — Today, Atotech, a leading global provider of specialty surface-finishing solutions, announced it has signed a definitive agreement to acquire Visutech Plating (“Visutech”), along with certain assets from its partner company, koenig-pa GmbH (“KPA”). Visutech Plating is a leading developer of process control and automation systems software used in electroplating and chemical treatment equipment, including many produced by Atotech. The transaction is anticipated to close by the end of August 2020. Terms of the transaction were not disclosed.This acquisition is part of Atotech’s strategy to expand its digitalization capabilities, speed up product development time, build its software-based business model, and become an even more important solutions provider to its customers. By more closely embedding...

GENEVA, Switzerland, Aug. 03, 2020 (GLOBE NEWSWIRE) — Etrion Corporation (“Etrion” or the “Company”) (TSX: ETX) (OMX: ETX), a solar independent power producer, will release its second quarter 2020 results before the market opens on Thursday, August 6, 2020.  Operations and Finance Update call A conference call webcast to present the Company’s second quarter 2020 Operations and Finance update will be held on Thursday, August 6, 2020, at 10:00 a.m. Eastern Standard Time (EST) / 4:00 p.m. Central European Time (CET).  Dial-in details:Conference ID: 3196284North America: +1-647-788-4919 / Toll Free: +1-877-291-4570 / Sweden Toll Free: 02-079-4343Webcast:A webcast will be available at https://www.webcaster4.com/Webcast/Page/1297/33372The Operations and Finance update call presentation and the Company’s condensed consolidated interim...

LONDON, Aug. 03, 2020 (GLOBE NEWSWIRE) — OKYO, the life sciences and biotechnology company, focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases and chronic pain, is pleased to announce that, further to the announcement made on Friday 31 July, the investor webinar, hosted by RedChip Companies, on Sunday, August 2, 2020 can be viewed at https://youtu.be/l8onUtOvSqQ.About OKYOOKYO Pharma Limited (LSE: OKYO) is a life sciences and biotechnology company admitted to listing on the standard segment of the Official List of the UK Financial Conduct Authority and to trading on the Main Market for listed securities of the London Stock Exchange plc. OKYO is focusing on the discovery and development of novel molecules to treat inflammatory dry eye diseases and chronic pain.Enquiries:For further...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, Aug. 03, 2020 (GLOBE NEWSWIRE) — Global Care Capital Inc. (CSE:HLTH, FRANKFURT:L6V1) (the “Company” or “Global Care”) a global investment company which engages in early stage investment opportunities in private and public companies, is pleased to provide a corporate update from CEO, Alex Somjen.For the period beginning April 1st, 2020 and ending June 30th, 2020, Global Care’s portfolio companies, High Standard Health Care Ltd. (“High Standard Health Care”) and ViraxClear through its joint venture partner, Shanghai Biotechnology Devices Ltd. (“ViraxClear”), on a consolidated basis, generated approximately CDN$ 3.95 million in gross revenue with a gross margin of approximately 39% from the sale of High Standard...

LONDON and RALEIGH, N.C., Aug. 03, 2020 (GLOBE NEWSWIRE) — Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that David Zaccardelli, Chief Executive Officer and President, and Mark Hahn, Chief Financial Officer, will present a company overview at the following virtual investor conferences in August 2020:BTIG Virtual Biotechnology ConferenceDate: Monday, August 10Time: 2:30 PM ETWedbush PacGrow Healthcare Virtual ConferenceDate: Wednesday, August 12Time: 11:30 AM ET40th Annual Canaccord Genuity Growth ConferenceDate: Thursday, August 13Time: 4:30 PM ETA live webcast of each event will be available on the Events and Presentations link on the Investors page of the Company’s website, www.veronapharma.com, and an audio replay will be available...

Oxurion NV appoints Grace Chang, M.D., Ph.D.as Chief Medical OfficerKey appointment as Oxurion progresses the clinical development ofTHR-149 and THR-687 building innovative Diabetic Macular Edema (DME) therapy franchiseLeuven, Belgium , 03 August 2020 – 08.00 CET – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company engaged in the development of next-generation therapies to treat diabetic eye disease, with a focus on diabetic macular edema,  today announces the appointment of Grace Chang, M.D., Ph.D. as the company’s Chief Medical Officer, effective August 1, 2020.Dr. Chang is a board-certified ophthalmologist and practicing vitreoretinal surgeon with deep expertise in ophthalmic drug research and development. She will be responsible for leading the Company’s clinical programs for both THR-687 and THR-149 as Oxurion looks...

NEW YORK and LONDON, Aug. 03, 2020 (GLOBE NEWSWIRE) — Tiziana Life Sciences plc (NASDAQ: TLSA; AIM: TILS) (the “Company” or “Tiziana“), a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, today announced it has entered into definitive agreements with investors for the purchase and sale of 11,009,615 of the Company’s American Depositary Shares (“ADSs”) at a price of $5.20 per ADS pursuant to a registered direct offering (the “Offering”). Each ADS offered represents two ordinary shares of nominal value £0.03 each (“Ordinary Shares”), following the recent forward split of the ADSs which became effective on 31 July 2020. The gross proceeds of the Offering will be approximately $57.25 million, before deducting placement agent fees...

HOUSTON, Aug. 03, 2020 (GLOBE NEWSWIRE) — VAALCO Energy, Inc. (NYSE: EGY; LSE: EGY) today announced the timing of its second quarter 2020 earnings release and conference call.The Company will issue its second quarter 2020 earnings release on Thursday, August 6 after the close of trading on the New York Stock Exchange and host a conference call to discuss its financial and operational results on Friday morning, August 7 at 8:00 a.m. Central Time (9:00 a.m. Eastern Time and 2:00 p.m. London Time).Interested parties in the United States may participate toll-free by dialing (877) 270-2148.  Interested parties in the United Kingdom may participate toll-free by dialing 08082389064. Other international parties may dial (412) 902-6510.  Participants should ask to be joined to the “VAALCO Energy Second Quarter 2020 Conference Call.”  This...